2nd Circ. Ruling Presents Risks For Drug Cos. In Litigation
Drugmakers that promote their products for off-label uses following the Second Circuit's landmark ruling on Monday could find themselves without their go-to defense in some personal injury lawsuits, attorneys say, since...To view the full article, register now.
Already a subscriber? Click here to view full article